LHON awareness

Views & Analysis

It’s hard to imagine suddenly losing your sight in your 20s, but that’s what happened to Richard Wheeler when he developed

News

City Therapeutics has finalised its IPO, raising $200 million for a pipeline of RNA interference therapies headed by a novel anticoagulant.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.